SurgoCap Partners LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001960830

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedTechnology TiltHigh Turnover how tags are computed

Q1 2026 · 14 positions · Total reported value $2.99B · Top-10 concentration 91.5% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 56.2% · 3 new · 1 cut · 5 exited

Active Share (vs S&P 500): 92.4% · vs QQQ: 91.3% — share of the book that differs from index weights (higher = more active) · ranking

In its Q1 2026 13F filing, SurgoCap Partners LP disclosed 14 equity positions with a combined reported value of $2.99B. The filing implies a focused portfolio: its ten largest positions account for 91.5% of reported value. HoldingsHub classifies the profile as Mid / Focused / Technology Tilt / High Turnover.

The largest disclosed positions as of Q1 2026 were CRS ($471.76M), GOOG ($427.10M), TSM ($374.47M). By sector, the heaviest allocations are Technology 38.2%, Health Care 24.2%. Versus the prior quarter, allocation shifted toward Industrials (+7.6pp), Health Care (+3.8pp) and away from Consumer Discretionary (-1.1pp), Technology (-1.8pp).

Versus the prior quarter, SurgoCap Partners LP opened 3 new positions, trimmed 1 and fully exited 5, a turnover rate of 56.2% of positions. The portfolio's overlap with the prior quarter was 55% of names.

The largest new positions opened in Q1 2026 were MDLN ($270.34M), GLW ($116.73M), V ($87.16M).

Of the 5 positions fully exited versus the prior quarter, the largest were BX ($319.70M), BSX ($244.02M), AVGO ($231.88M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • MDLN MEDLINE INC · $270.34M
  • GLW CORNING INC · $116.73M
  • V VISA INC · $87.16M

Fully Exited (vs previous quarter)

  • BX BLACKSTONE INC · prev qtr: $319.70M
  • BSX BOSTON SCIENTIFIC CORP · prev qtr: $244.02M
  • AVGO BROADCOM INC · prev qtr: $231.88M
  • HLT HILTON WORLDWIDE HLDGS INC · prev qtr: $144.69M · history
  • GWRE GUIDEWIRE SOFTWARE INC · prev qtr: $144.64M
  • AWI ARMSTRONG WORLD INDS INC NEW · prev qtr: $72.02M

Insider Transactions (Form 4)

Latest SurgoCap Partners LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

SurgoCap Partners LP, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 13 positions worth $3.09B in total. HoldingsHub carries 11 quarters of its filings (Q4 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-126914 (status: Approved), registered 2022-12-07
  • Regulatory AUM (Form ADV): $7.35B as of 2026-06-26
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 1 hedge funds
  • Website: surgocap.com

Portfolio Structure

  • 13 positions · $3.09B reported value (Q2 2026)
  • Top 10 holdings = 92.2% of reported value
  • Largest position: TSM (TAIWAN SEMICONDUCTOR MANUFAC) at 14.0%
  • Average position size: $237.96M

Sector Tilt

  • Information Technology 33.4%
  • Health Care 22.1%
  • Industrials 20.3%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 3 new, 4 added, 6 reduced, 4 exited

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Technology 38.2%
Health Care 24.2%
Industrials 19.7%
Financials 15.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.20M $471.76M 15.75%
15.75%
Add
2 1.49M $427.10M 14.26%
14.26%
Add
3 1.11M $374.47M 12.50%
12.50%
Hold
4 1.02M $307.10M 10.25%
10.25%
Add
5 348.73K $301.78M 10.08%
10.08%
Reduce
6 6.08M $270.34M 9.03%
9.03%
New
7 1.01M $175.81M 5.87%
5.87%
Add
8 333.03K $153.52M 5.13%
5.13%
Add
9 9.87M $141.78M 4.73%
4.73%
Reduce
10 858.51K $116.73M 3.90%
3.90%
New
11 288.37K $87.16M 2.91%
2.91%
New
12 5.86M $66.61M 2.22%
2.22%
Hold
13 515.73K $61.18M 2.04%
2.04%
Add
14 1.87M $39.48M 1.32%
1.32%
Hold

FAQ

What did SurgoCap Partners LP buy in 2026-Q1?

In its 2026-Q1 13F filing, SurgoCap Partners LP reported 14 equity positions worth $2.99B in aggregate; its largest disclosed positions were CRS ($471.76M), GOOG ($427.10M), TSM ($374.47M).

How large is SurgoCap Partners LP's portfolio?

SurgoCap Partners LP reported $2.99B of long equity holdings across 14 positions as of 2026-Q1. Top-10 holdings account for 91.5% of reported value.

What is SurgoCap Partners LP's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Technology Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/surgocap-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →